Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-03-16 Purchase | 2023-03-16 5:10 pm | ORAMED PHARMACEUTICALS INC. | ORMP | KIDRON NADAV President and CEO | 26,000 | $2.039 | $53,014 | 1,179,098 (Indirect Direct) | View |
| 2023-03-14 Purchase | 2023-03-15 5:25 pm | ORAMED PHARMACEUTICALS INC. | ORMP | KIDRON NADAV President and CEO | 100,000 | $2.01 | $201,000 | 1,153,098 (Indirect Direct) | View |
| 2021-08-09 Sale(A) | 2021-12-07 4:30 pm | ORAMED PHARMACEUTICALS INC. | ORMP | KIDRON NADAV President and CEO 10% Owner | 220,000 | $20.11 | $4,423,144 | 738,209 (Direct) | View |
| 2021-08-09 Sale | 2021-08-11 5:15 pm | ORAMED PHARMACEUTICALS INC. | ORMP | KIDRON NADAV President and CEO 10% Owner | 220,000 | $20.11 | $4,423,144 | 648,573 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-04 Option Award | 2024-01-08 4:41 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | KIDRON NADAV President and CEO | 329,000 | $0 | 1,907,098 (Direct) | View |
| 2023-05-26 Option Award | 2023-05-31 5:10 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | KIDRON NADAV President and CEO | 120,000 | $0 | 1,578,098 (Direct) | View |
| 2023-04-17 Option Award | 2023-04-20 06:00 am | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | KIDRON NADAV President and CEO | 279,000 | $0 | 1,458,098 (Direct) | View |
| 2022-10-27 Gift | 2022-10-28 9:30 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | KIDRON NADAV President and CEO | 25,000 | $0 | 1,053,098 (Direct) | View |
| 2022-08-01 Tax Withholding | 2022-08-01 8:00 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | KIDRON NADAV President and CEO | 12,631 | $8.36 | 1,078,098 (Direct) | View |
| 2022-07-28 Option Award | 2022-08-01 8:00 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | KIDRON NADAV President and CEO | 160,000 | $0 | 1,078,098 (Direct) | View |
| 2022-01-03 Option Award(A) | 2022-01-11 8:30 pm | N/A 2032-01-03 | ORAMED PHARMACEUTICALS INC. | ORMP | KIDRON NADAV President and CEO | 320,000 | $0 | 1,037,729 (Direct) | View |
| 2022-01-03 Tax Withholding(A) | 2022-01-11 8:30 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | KIDRON NADAV President and CEO | 48,752 | $13.89 | 1,037,729 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 8:41 pm | N/A 2032-01-03 | ORAMED PHARMACEUTICALS INC. | ORMP | KIDRON NADAV President and CEO | 320,000 | $0 | 1,057,729 (Direct) | View |
| 2022-01-03 Tax Withholding | 2022-01-05 8:41 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | KIDRON NADAV President and CEO | 48,752 | $13.89 | 1,057,729 (Direct) | View |
| 2021-12-30 Gift | 2021-12-30 9:31 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | KIDRON NADAV President and CEO | 20,000 | $0 | 766,481 (Direct) | View |
| 2021-12-28 Tax Withholding | 2021-12-30 9:31 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | KIDRON NADAV President and CEO | 31,728 | $12.98 | 766,481 (Direct) | View |
| 2021-12-03 Gift | 2021-12-07 5:15 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | KIDRON NADAV President and CEO | 20,000 | $0 | 818,209 (Direct) | View |
| 2021-08-31 Option Award(A) | 2021-12-07 4:30 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | KIDRON NADAV President and CEO | 100,000 | $0 | 838,209 (Direct) | View |
| 2021-08-31 Option Award | 2021-09-02 4:43 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | KIDRON NADAV President and CEO | 100,000 | $0 | 748,573 (Direct) | View |
| 2021-02-03 Option Award | 2021-02-08 5:30 pm | N/A 2031-02-03 | ORAMED PHARMACEUTICALS INC. | ORMP | KIDRON NADAV President and CEO 10% Owner | 150,000 | $0 | 150,000 (Direct) | View |
| 2020-01-08 Option Award | 2020-01-14 4:06 pm | N/A 2030-01-08 | ORAMED PHARMACEUTICALS INC. | ORMP | KIDRON NADAV President and CEO 10% Owner | 190,000 | $0 | 190,000 (Direct) | View |